Skip to main content

Jackson Financial Inc.

For the period ended Sep 30, 2025. Filed Nov 4, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 4, 2025

JXN$131.69-0.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheet

Condensed Consolidated Balance Sheets

(in millions, except share data)

September 30,December 31,
20252024
Assets · (Unaudited)
Investments:
Debt Securities, available-for-sale, net of allowance for credit losses of $11 and $39 at September 30, 2025 and December 31, 2024, respectively (amortized cost: 2025 $49,228; 2024 $45,007)$46,087$40,289
Debt Securities, at fair value under fair value option3,4823,046
Equity securities, at fair value180197
Mortgage loans, net of allowance for credit losses of $143 and $121 at September 30, 2025 and December 31, 2024, respectively9,5719,462
Mortgage loans, at fair value under fair value option349449
Policy loans (including $3,592 and $3,489 at fair value under the fair value option at September 30, 2025 and December 31, 2024, respectively)4,4874,403
Freestanding derivative instruments486297
Other invested assets3,0492,864
Total investments67,69161,007
Cash and cash equivalents4,5623,767
Accrued investment income585529
Deferred acquisition costs11,65411,887
Reinsurance recoverable, net of allowance for credit losses of $26 and $27 at September 30, 2025 and December 31, 2024, respectively20,05321,830
Reinsurance recoverable on market risk benefits, at fair value116121
Market risk benefit assets, at fair value8,5218,899
Deferred income taxes, net573480
Other assets757787
Separate account assets239,046229,143
Total assets$353,558$338,450
Liabilities and Equity
Liabilities
Reserves for future policy benefits and claims payable$10,912$11,072
Other contract holder funds65,28958,312
Market risk benefit liabilities, at fair value3,7333,774
Funds withheld payable under reinsurance treaties (including $3,775 and $3,667 at fair value under the fair value option at September 30, 2025 and December 31, 2024, respectively)15,49816,742
Long-term debt2,0302,034
Repurchase agreements and securities lending payable1,0321,554
Collateral payable for derivative instruments92150
Freestanding derivative instruments199361
Notes issued by consolidated variable interest entities, at fair value under fair value option (see Note 4)2,6182,343
Other liabilities2,6082,983
Separate account liabilities239,046229,143
Total liabilities343,057328,468
Commitments, Contingencies, and Guarantees (see Note 16)
Equity
Series A non-cumulative preferred stock and additional paid in capital, $1.00 par value per share: 24,000 shares authorized; 22,000 shares issued and outstanding at September 30, 2025 and December 31, 2024; liquidation preference $25,000 per share (see Note 19)533533
Common stock; 1,000,000,000 shares authorized, $0.01 par value per share and 68,333,010 and 73,380,643 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively (see Note 19)11
Additional paid-in capital6,0566,046
Treasury stock, at cost; 26,155,305 and 21,107,672 shares at September 30, 2025 and December 31, 2024, respectively(1,493)(1,007)
Accumulated other comprehensive income (loss), net of tax expense (benefit) of $(401) and $(311) at September 30, 2025 and December 31, 2024, respectively(2,609)(3,522)
Retained earnings7,7417,713
Total shareholders' equity10,2299,764
Noncontrolling interests272218
Total equity10,5019,982
Total liabilities and equity$353,558$338,450
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.